{
    "organizations": [],
    "uuid": "49e03263dbc5ebbd89a95b91fd1fceab6c5488e8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-lysogene-had-141-million-euros-of/brief-lysogene-had-14-1-million-euros-of-cash-and-cash-equivalent-as-of-december-31-2017-idUSFWN1R80XK",
    "ord_in_thread": 0,
    "title": "BRIEF-Lysogene Had 14.1 Million Euros Of Cash And Cash Equivalent As Of December 31, 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - LYSOGENE SA:\n* WELL POSITIONED TO START OUR PHASE III PIVOTAL TRIAL IN 2018 FOR LYS-SAF302\n* LYSOGENE HAD EUR 14.1 MILLION OF CASH AND CASH EQUIVALENT AS OF DECEMBER 31, 2017.\n* ALSO PLEASED WITH PROGRESS OF GM1 GANGLIOSIDOSIS PROGRAMME WITH GOAL TO START IN CLINICAL DEVELOPMENT IN 2019\n* LOSSES PER SHARE INCREASED TO EUR 1.52 IN 2017 FROM EUR 0.91 IN 2016\n* FY NET LOSS EUR 17.8 MILLION VERSUS LOSS EUR 7.5 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-27T00:36:00.000+03:00",
    "crawled": "2018-03-27T12:05:30.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "lysogene",
        "sa",
        "well",
        "positioned",
        "start",
        "phase",
        "iii",
        "pivotal",
        "trial",
        "lysogene",
        "eur",
        "million",
        "cash",
        "cash",
        "equivalent",
        "december",
        "also",
        "pleased",
        "progress",
        "gm1",
        "gangliosidosis",
        "programme",
        "goal",
        "start",
        "clinical",
        "development",
        "loss",
        "per",
        "share",
        "increased",
        "eur",
        "eur",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}